UniProtKB/Swiss-Prot P06737: Variant p.Ile806Leu

Glycogen phosphorylase, liver form
Gene: PYGL
Feedback?

Variant information Variant position:

806 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Isoleucine (I) to Leucine (L) at position 806 (I806L, p.Ile806Leu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Similar physico-chemical property. Both residues are medium size and hydrophobic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs34313873 [ dbSNP | Ensembl ]

Sequence information Variant position:

806 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

847 The length of the canonical sequence.
Location on the sequence:

DKVSQLYMNPKAWNTMVLKN I AASGKFSSDRTIKEYAQNIW The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         DKVSQLYMNPKAWNTMVLKNIAASGKFSSDRTIKEYAQNIW

Mouse                         EKVSQLYMNQKAWNTMVLKNIAASGKFSSDRTIKEYAKDIW

Rat                           EKVSQLYMNQKAWNTMVLRNIAASGKFSSDRTIREYAKDIW

Bovine                        EKVSQLYMNPKAWNIMVLKNIAASGKFSSDRTIKEYARDIW

Sheep                         EKVSQLYMNPKAWNIMVLKNIAASGKFSSDRTIKEYARDIW

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	2 – 847	Glycogen phosphorylase, liver form
Modified residue	796 – 796	N6-acetyllysine
Mutagenesis	796 – 796	K -> Q. Decreased glycogen phosphorylase activity.
Mutagenesis	796 – 796	K -> R. Decreased acetylation; when associated with R-470.
Helix	795 – 806

Literature citations
No reference for the current variant in UniProtKB/Swiss-Prot.

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.